Africa: Is Africa Ready to Produce a Malaria Vaccine?
[DW] BioNTech wants to continue the success of its COVID-19 vaccine and use mRNA technology to develop shots against malaria. But is production in Africa realistic? (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 11, 2021 Category: Infectious Diseases Source Type: news

Zimbabwe: World's First Malaria Vaccine Generates Remarkable Results
[The Herald] Correspondent (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 7, 2021 Category: Infectious Diseases Source Type: news

Africa: Innovative Use of World's First Malaria Vaccine Generates Remarkable Results
[IPS] In the midst of the tragedy and turmoil caused by the COVID-19 pandemic, it's gratifying to see work continuing in Africa to find new ways of fighting malaria, a very old disease that has been a formidable foe for thousands of years and still kills 400,000 people every year, most of them African children under five years old. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - September 2, 2021 Category: Infectious Diseases Source Type: news

Innovative Use of World ’s First Malaria Vaccine Generates Remarkable Results and a Life-Saving Opportunity
Malaria still kills 400,000 people every year, most of them African children under five years old. RTS,S is the first malaria vaccine shown to reduce malaria and life-threatening severe malaria in young children. Credit: Mercedes Sayagues/IPSBy Kesete AdmasuSep 1 2021 (IPS) In the midst of the tragedy and turmoil caused by the COVID-19 pandemic, it’s gratifying to see work continuing in Africa to find new ways of fighting malaria, a very old disease that has been a formidable foe for thousands of years and still kills 400,000 people every year, most of them African children under five years old. Scientists from the ...
Source: IPS Inter Press Service - Health - September 1, 2021 Category: International Medicine & Public Health Authors: Kesete Admasu Tags: Africa Headlines Health Malaria Source Type: news

Ghana: Profile - Dr. Kwaku Poku Asante, Director At Kintampo Health Research Centre, Ghana Health Service
[WHO] In this Q&A, Dr Kwaku Poku Asante, director of the Kintampo Health Research Centre in Ghana reflects on the potential implications of the RTS,S seasonal vaccination study findings for Ghana and other countries in the region. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - August 31, 2021 Category: Infectious Diseases Source Type: news

Malaria Vaccine + Antimalarial = 70% Reduction in Disease, Death Malaria Vaccine + Antimalarial = 70% Reduction in Disease, Death
The study found the combination reduces the incidence of malaria by 62% against clinical malaria infection, 70% against severe malaria, and 73% against death from malaria compared with SMC alone.Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - August 31, 2021 Category: Respiratory Medicine Tags: Infectious Diseases News Source Type: news

Trial suggests malaria sickness could be cut by 70%
Seasonal vaccines and drugs could save millions of young lives in Africa, researchers say. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 26, 2021 Category: Consumer Health News Source Type: news

Prioritising Profits Reversed Health Progress
By Anis Chowdhury and Jomo Kwame SundaramSYDNEY and KUALA LUMPUR, Aug 24 2021 (IPS) Instead of a health system striving to provide universal healthcare, a fragmented, profit-driven market ‘non-system’ has emerged. The 1980s’ neo-liberal counter-revolution against the historic 1978 Alma-Ata Declaration is responsible. Alma-Ata a big step forward Neoliberal health reforms over the last four decades have reversed progress at the World Health Organization (WHO) Assembly in the capital of the then Socialist Republic of Kazakhstan, now known as Almaty. Anis ChowdhuryThen, 134 WHO Member States reached a histor...
Source: IPS Inter Press Service - Health - August 24, 2021 Category: International Medicine & Public Health Authors: Anis Chowdhury and Jomo Kwame Sundaram Tags: Development & Aid Economy & Trade Education Environment Global Headlines Health Human Rights TerraViva United Nations Source Type: news

First Came an Earthquake. Then a Hurricane. Now, Haiti is Bracing for an Outbreak of Disease.
On Aug. 14, a devastating 7.2-magnitude earthquake hit southwestern Haiti, leaving 2,189 people dead, 12,268 injured and at least 332 missing. Days later, Tropical Storm Grace swept over the ravaged landscape, hampering the complicated search and rescue mission. Yet aid groups say this is only the beginning of the crisis. The island country of nearly 12 million people has faced one disaster after another in the space of a few weeks. In July, President Jovenel Moïse was assassinated amid mounting allegations of corruption. The country has been struggling with poverty, disease and a fractured infrastructure since a cata...
Source: TIME: Health - August 20, 2021 Category: Consumer Health News Authors: Eloise Barry Tags: Uncategorized Londontime Natural Disasters Source Type: news

First Came an Earthquake. Then a Hurricane. Now, Haiti is Bracing for an Outbreak of Disease
On Aug. 14, a devastating 7.2-magnitude earthquake hit southwestern Haiti, leaving 2,189 people dead, 12,268 injured and at least 332 missing. Days later, Tropical Storm Grace swept over the ravaged landscape, hampering the complicated search and rescue mission. Yet aid groups say this is only the beginning of the crisis. The island country of nearly 12 million people has faced one disaster after another in the space of a few weeks. In July, President Jovenel Moïse was assassinated amid mounting allegations of corruption. The country has been struggling with poverty, disease and a fractured infrastructure since a cata...
Source: TIME: Health - August 20, 2021 Category: Consumer Health News Authors: Eloise Barry Tags: Uncategorized Londontime Natural Disasters Source Type: news

BioNTech profits soar as Covid vaccine demand surges
Expected €15.9bn revenues will enable big push into cancer, TB and malaria research (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 9, 2021 Category: Pharmaceuticals Source Type: news

Senate Bill a Big Win for Health Workers around the Globe
By David Bryden, Director of the Frontline Health Workers Coalition and senior policy and advocacy advisor at IntraHealth International Photo of health workers in Mali by Nana Kofi Acquah for IntraHealth International. IntraHealth leads the secretariat for the Frontline Health Workers Coalition.August 05, 2021Even as the world is struggling to address COVID-19, we must plan and prepare for future pandemics. In fact, a recent estimate shows that the probability of a future zoonotic spillover event resulting in a pandemic of COVID-19 magnitude or larger is high: a 22-28% chance within the next ten years. W...
Source: IntraHealth International - August 5, 2021 Category: International Medicine & Public Health Authors: kseaton Tags: Policy & Advocacy Global health security Health Workforce Systems Source Type: news

Africa: WHO Director-General's Opening Remarks At the mRNA Malaria Vaccine Event
[WHO] Mr Holm Keller, (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - August 5, 2021 Category: Infectious Diseases Source Type: news

Africa: Biontech Starts Work on Malaria Vaccines in Africa
[East African] German biotech company BioNTech SE has announced the start of its malaria project, which aims to develop safe, effective and sustainable malaria vaccine supply solutions in Africa. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - August 4, 2021 Category: Infectious Diseases Source Type: news

BioNTech seeks to develop a more effective malaria vaccine
German group behind successful Covid jab hopes to have a vaccine in trials by 2022 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 26, 2021 Category: Pharmaceuticals Source Type: news

Vaccine maker BioNTech to use mRNA tech to target malaria
Pharmaceutical company BioNTech says it wants to use the mRNA technology behind its coronavirus vaccine to target malaria (Source: ABC News: Health)
Source: ABC News: Health - July 26, 2021 Category: Consumer Health News Tags: Health Source Type: news

< a href= " /news-events/nih-research-matters/malaria-vaccines-provide-strong-lasting-immunity " > Malaria vaccines provide strong and lasting immunity < /a >
Researchers developed a malaria vaccination strategy that provided broad, long-lasting protection in controlled clinical trials. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - July 13, 2021 Category: Consumer Health News Source Type: news

EXPENDABLE children: The WHO is experimenting with controversial malaria vaccine on children in Africa
(Natural News) As much of humanity willingly subjects itself to a massive global vaccine experiment in hopes of gaining protection against COVID-19, young African children are being subjected to experiments with a highly controversial malaria vaccine without informed consent for their parents. This is according to Jeremy R. Hammond of the Foreign Policy Journal, who... (Source: NaturalNews.com)
Source: NaturalNews.com - July 12, 2021 Category: Consumer Health News Source Type: news

Malaria vaccine with live parasites given with cheap drug can give 100% protection against disease
A malaria vaccine that contains live parasites has been found 100 per cent effective in a small-scale trial, when taken alongside a £0.86 drug, a study by the US National Institutes of Health has found. (Source: the Mail online | Health)
Source: the Mail online | Health - July 1, 2021 Category: Consumer Health News Source Type: news

Investigational malaria vaccine gives strong, lasting protection
Phase 1 trials conducted at NIH Clinical Center. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - June 30, 2021 Category: American Health Source Type: news

Investigational malaria vaccine gives strong, lasting protection
(NIH/National Institute of Allergy and Infectious Diseases) Two U.S. Phase 1 clinical trials of a novel candidate malaria vaccine have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites. The vaccine combines live parasites with either of two widely used antimalarial drugs -- an approach termed chemoprophylaxis vaccination. A Phase 2 clinical trial of the vaccine is now underway in Mali, a malaria-endemic country. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 30, 2021 Category: Infectious Diseases Source Type: news

Africa: Gavi and the Global Fund Sign Groundbreaking Agreement With International Federation of Accountants to Support in-Country Financial Management
[Global Fund] Geneva -- Global health leaders Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria have joined forces with the International Federation of Accountants (IFAC) to contribute to, and support, the implementation of robust accounting practices in the public health sector and to improve overall financial management of donor funds by implementing countries. (Source: AllAfrica News: HIV-Aids and STDs)
Source: AllAfrica News: HIV-Aids and STDs - June 24, 2021 Category: Infectious Diseases Source Type: news

Global Herd Immunity Remains Out of Reach Because of Inequitable Vaccine Distribution – 99% of People in Poor Countries Are Unvaccinated
This article is republished from The Conversation under a Creative Commons license. Read the original article. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - June 24, 2021 Category: International Medicine & Public Health Authors: External Source Tags: Headlines Health Poverty & SDGs Source Type: news

mRNA vaccine yields full protection against malaria in mice
(Walter Reed Army Institute of Research) WRAIR scientists and partners developed an mRNA vaccine that protects against malaria in animal models. Malaria remains a large public health and economic burden worldwide as well as a danger to deployed Service Members. This vaccine uses mRNA accompanied by a lipid nanoparticle to prompt cells to code for circumsporozoite protein, which then triggers an immune response against malaria. The vaccine achieved high levels of protection in mice, encouraging further development for the novel platform. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 18, 2021 Category: Infectious Diseases Source Type: news

'Mosquito smoothie' innovation boosts future malaria vaccine potential
(Imperial College London) A faster method for collecting pure malaria parasites from infected mosquitos could accelerate the development of new, more potent malaria vaccines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2021 Category: International Medicine & Public Health Source Type: news

To Improve Global Health Security, We Must Not Abandon Tackling Existing Epidemics
Over 600 million people in Africa require treatment for an NTD, making up 35% of the global burden. Credit: Uniting to Combat NTDsBy Thoko Elphick-PooleyHOVE, United Kingdom, Jun 11 2021 (IPS) As world leaders come together in the UK for the G7, the global response to COVID-19 and how we can build a better defence system against infection is at the forefront of discussions.  Whilst we applaud the incredible global efforts in tackling COVID-19 and support calls for vaccines to be shared equitably across the world, we also urge G7 leaders not to abandon efforts to tackle existing epidemics such as neglected tropical dis...
Source: IPS Inter Press Service - Health - June 11, 2021 Category: International Medicine & Public Health Authors: Thoko Elphick Pooley Tags: Headlines Health TerraViva United Nations Neglected Tropical Diseases (NTDs) Source Type: news

St. Louis Character: How Saint Louis University's Dr. Daniel Hoft became one of the nation's leading vaccine experts
On a Peace Corps trip to Malaysia, Dr. Daniel Hoft's malaria research launched him into a 40-year career studying infectious diseases and vaccinology. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2021 Category: Pharmaceuticals Authors: Maddy Simpson Source Type: news

The 10 Most Important Health Breakthroughs You Missed During the Pandemic
While most eyes were on COVID-19, researchers have also made groundbreaking advancements in other fields. Here’s a look. The other big vaccine news Public-health officials have long sought a vaccine against malaria, which infects up to 600 million people a year and kills 400,000, mostly children. This year, there was dramatic prog­ress toward that goal. In a study of 450 children in Burkina Faso, published in the Lancet in April, researchers reported that a new malaria vaccine, called R21, is 77% effective—just clearing the World Health Organization’s 75% efficacy standard. However, the sample gro...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 feature Innovation Magazine Source Type: news

Preventing the Next Health Crisis Depends on Health Workers. We Need 18 Million More
Over 115,000 health and care workers died during the COVID-19 pandemic. As a physician who’s cared for patients with COVID-19, malaria and Ebola, I’ve seen too many colleagues make the ultimate sacrifice on the frontlines. I’m not surprised experts responding to TIME’s survey ranked bolstering the world’s public health workforce, particularly in rural and remote regions, as one of the top five of nearly 50 strategies to prepare for the next pandemic. But I’m concerned they ranked this the least feasible strategy amongst the top five. Experts ranked high the need for new systems to raise ...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Raj Panjabi Tags: Uncategorized COVID-19 health Magazine Source Type: news

Optimizing immunization with Sanaria ® PfSPZ-CVac malaria vaccine
(Sanaria Inc.) Sanaria and its collaborators have had to take a step by step empirical approach to optimizing immunization with PfSPZ vaccines to achieve a safe, effective, durable, and broadly protective malaria vaccine. Two recent landmark malaria vaccine studies have moved the optimization process forward and highlighted the strong protective efficacy of Sanaria ® PfSPZ-CVac in malaria-na ï ve adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2021 Category: International Medicine & Public Health Source Type: news

What Are Some Indications for Using Dexamethasone?
Discussion Corticosteroids are a group of drugs which can be naturally or synthetically produced. Naturally occurring substances are produced in the adrenal gland, and are protein-bound (primarily corticosteroid-binding globulin and albumin). In the target tissues, they may need to be converted to an active substance. They are then reduced, oxidized, hydroxylated or conjugated as measures to inactivate them. Synthetic steroids have less protein binding and depending on their structure are more or less resistant to inactivation. Prednisone is the glucocorticoid most often used for treatment, especially as it has a short hal...
Source: PediatricEducation.org - June 7, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

How COVID-19 Is Revolutionizing Health Care Around the World
In 2020 alone, there were at least 3 million deaths from COVID-19, though the true figure is probably 2-3 times higher. In 2021, the COVID-19 pandemic continues to rage on and is likely to last well into 2022 and beyond. For ten weeks in a row, from the first week of February, 2021, new daily cases globally rose, driven in part by virus variants and by many countries ending public health measures too soon. There are still around 600,000 new cases every day. Nations like Brazil, Canada, India, Iran, and Turkey—as well as some U.S. states like Michigan and Minnesota—recently experienced COVID-19 surges that in so...
Source: TIME: Health - June 3, 2021 Category: Consumer Health News Authors: Gavin Yamey and Madhukar Pai Tags: Uncategorized COVID-19 Source Type: news

Atlas of malaria parasite gene activity provides new targets for drugs and vaccines
(Imperial College London) Researchers have mapped in fine detail the genetic changes malaria parasites go through as they prepare to infect people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 27, 2021 Category: International Medicine & Public Health Source Type: news

Africa: Hope For A Malaria-Free Africa
[allAfrica] In recent decades, the world has made remarkable progress in the fight against malaria. Over 20 years of investment, commitment, and action have saved over 7.6 million lives and prevented over 1.5 billion malaria cases. We've discovered new ways of protecting ourselves from the deadly mosquito bite -- with insecticide-treated mosquito nets, effective antimalarial treatments, and--most recently--promising new innovations such as gene drive and malaria vaccines bringing us one step close (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - May 25, 2021 Category: Infectious Diseases Source Type: news

Africa: Good News Emerges About a Malaria Vaccine
[CFR] In Africa and elsewhere, COVID-19 dominates media attention. Yet malaria has probably killed four times as many as COVID-19 over the last year in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 19, 2021 Category: African Health Source Type: news

Uganda: Breakthrough As New Malaria Vaccine Attains 77pc Efficacy
[Monitor] The Tanzanian government said May 14 that it was closely monitoring the recently developed malaria vaccine that has proved to be 'highly effective' in clinical trials. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2021 Category: African Health Source Type: news

T ü bingen study raises hope for effective malaria vaccine
(German Center for Infection Research) At the University Hospital of Tuebingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine and Dr. Rolf Fendel, Research Group Leaderat the Institute of Tropical Medicine partnered with the German Center for Infection Research (DZIF), was able to show that the vaccine, " Sanaria ® PfSPZ-CVac " , which is being developed in Tuebingen together with the biotechnology company Sanaria Inc., provides 77 percent cross-strain protection against malaria parasites. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 5, 2021 Category: Infectious Diseases Source Type: news

Promising malaria vaccine enters final stage of clinical testing in West Africa
(University of Oxford) R21/Matrix-M, a malaria vaccine developed at the Jenner Institute, University of Oxford, showed efficacy of 77% over 12 months in a recently reported phase IIb trial. First vaccinations have now begun in Mali in a larger phase III trial which is hoped to lead to licensure of this malaria vaccine by 2023. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 5, 2021 Category: Infectious Diseases Source Type: news

Kenya: Kenya Administers 450,000 Doses of Malaria Vaccine in Pilot Programme
[East African] Since the malaria vaccine launch in Africa in September 2019, Kenya has managed to administer the total four doses to 4,017 children, says the Ministry of Health. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 30, 2021 Category: Infectious Diseases Source Type: news

Is There Any Vaccine for Malaria
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 28, 2021 Category: General Medicine Source Type: news

Ghana: Over 2,000 Children Vaccinated Against Malaria in AEE District
[Ghanaian Times] Ajumako -- A total of 21,951 children under five years have since 2019 been vaccinated against malaria in the Ajumako-Enyan-Essiam (AEE) District of the Central Region. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 27, 2021 Category: Infectious Diseases Source Type: news

New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso. (Source: The Scientist)
Source: The Scientist - April 26, 2021 Category: Science Tags: News & Opinion Source Type: news

Rwanda: Rwanda Optimistic About Latest Breakthrough in Search for a Malaria Vaccine
[New Times] Officials at Rwanda Biomedical Centre (RBC) have said they are optimistic about the recent unprecedented developments in the search for a malaria vaccine, and hope soon there will be a vaccine to complement the existing measures to fight the disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2021 Category: Infectious Diseases Source Type: news

Africa: 'Landmark' Step in Malaria Vaccines As First Trial Meets WHO Target
[RFI] As the world marks World Malaria Day, a new vaccine has proven 77 percent effective in trials on infants, according to British researchers, in what could prove to be a potential game-changer against the deadly mosquito-borne disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Malaria Vaccine in Nigeria Ready in 6 Months, Ned Nwoko Foundation Says
[Vanguard] The Prince Ned Nwoko Foundation has said that a vaccine for malaria in Nigeria would be available in the next six months. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Malaria Vaccine Ready in 6 Months, Ned Nwoko Foundation Says
[Vanguard] The Prince Ned Nwoko Foundation has said that a vaccine for malaria in Nigeria would be available in the next six months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 26, 2021 Category: African Health Source Type: news

New vaccine success for Oxford is truly remarkable | Kenan Malik
Malaria has still not been eradicated in the poorest countries, but that could be about to changeAnother vaccine from Oxford ’s Jenner Institute and one that may have a greater impact than that against Covid-19. Results from trials of itsmalaria vaccine, R21, show it to be 77% effective. If replicated in larger scale trials, it would be a remarkable breakthrough. Malaria kills more than400,000 people a year, almost all in sub-Saharan Africa, and mainly children. Until now, the only approved anti-malarial vaccine, Mosquirix, has had a low level of efficacy – among young children it reduced cases by 39%; in infan...
Source: Guardian Unlimited Science - April 25, 2021 Category: Science Authors: Kenan Malik Tags: Malaria Society Infectious diseases Medical research Source Type: news

Nigeria: Good News for Nigeria, Others As Potential Malaria Vaccine Surpasses 75 Percent Efficacy
[Premium Times] Malaria is a major public health problem in 97 countries - particularly, in Sub-Saharan Africa (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 24, 2021 Category: Infectious Diseases Source Type: news

Kenya: Kenya to Pilot Another Malaria Vaccine Trial
[Nation] Kenya is among four African countries that will carry out a larger trial in nearly 5,000 children, on a malaria vaccine proven to be 77 per cent effective. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 24, 2021 Category: Infectious Diseases Source Type: news

New malaria vaccine offers 77% protection against deadly parasite, researchers say
A new malaria vaccine developed by researchers at the University of Oxford provides 77% protection against the mosquito-borne parasite for one year, a study published online Friday by the Lancet found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 23, 2021 Category: Consumer Health News Source Type: news